July 19, 2022 NurExone Exosomes to Be Used in Cutting Edge Molecular Research at Hebrew University’s Burstyn-Cohen Lab Read More
July 11, 2022 NurExone to Collaborate with Polyrizon for Intranasal Administration of Cutting-Edge Exosome-Therapy Read More
June 22, 2022 NurExone Biologic Inc. to Begin Trading on TSX Venture Exchange and Retains Market Maker Read More
June 16, 2022 NurExone Biologic Inc. (Formerly, Enerspar Corp.) Announces Completion of Reverse Takeover Transaction Read More
May 18, 2022 EnerSpar and NurExone Announce Conditional Acceptance of Proposed Reverse Takeover Transaction Read More
March 15, 2022 EnerSpar and Israeli-Based Nurexone Provide Update on Progress to Closing RTO Read More
August 30, 2021 EnerSpar and Israeli-Based Nurexone Announce RTO and New NI 43-101 Filed by EnerSpar Read More
